Given that our data support CCT as an essential enabler of the migratory phenotype in SK-N-AS and IMR-32 cells, we tested whether CCT2 could be used as a diagnostic indicator for invasive neuroblastoma cells. The gene discussed is CCT2; the disease is neuroblastoma.